We can help you
Your clinical trials (in terms of costs and time)
go / no-go
in pay for outcome scenarios
- November 25th, 2021
Radiomics announces the strategic support of OncoDNA in its prospective clinical trial SALMON
The two Belgian companies will work towards a better understanding of non-small cell lung cancer biology and characterization of the tumors using of AI technology
- November 17th, 2021
Radiomics secures €6 Million to fund new projects and initiatives
Radiomics announced that it has secured €6 Million in a pre-series B funding led by its main investors (Epimede and Noshaq) and backed by its original funders, its management team, some banks and non-dilutive financing from Walloon Regional Authorities in support of R&D Projects.
- November 9th, 2021
Kazia Therapeutics and Radiomics collaborate in development of novel therapy
Radiomics, AI-powered imaging research organization, and Kazia Therapeutics, Australian oncology company developing innovative, high-impact drugs for cancer, announced that they have entered into a partnership to enhance imaging insights for the clinical development of EVT801.